Combined effects of intraperitoneal administration of recombinant interleukin-2 and streptococcal preparation OK-432 in murine tumors
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Immunology
Reference32 articles.
1. Interkeukin-2 administered in vivo induces the growth and augments the function of cultured T cell in vivo;Cheever;J. biol. Res. Modif.,1984
2. Cytolytic and proliferative active of a permanent T killer cell line;Dennert;Nature, Lond.,1979
3. Interleukin-2 dependence of human natural killer (NK) cell activity;Domzing;J. Immun.,1983
4. The biochemistry, biology and role of interleukin-2 in the induction of cytotoxic T cell and antibody-forming B cell response;Farrar;Immun. Rev.,1982
5. Studies of immunotherapy for malignant urogenital tumors: changes in K-cell population of the peripheral blood in patients with malignant tumors and the significance of antibody dependent cell-mediated cytotoxicity (ADCC) in OK-432 immunotherapy;Fujioka;Jpn. J. Urol.,1987
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Inhibition of head and neck metastatic and/or recurrent cancer by local administration of multi-cytokine inducer OK-432;The Journal of Laryngology & Otology;1996-05
2. Synergistic Effects Between Recombinant Interleukin-2 and the Synthetic Immunomodulator Murabutide: Selective Enhancement of Cytokine Release and Potentiation of Antitumor Activity;Journal of Interferon & Cytokine Research;1996-02
3. Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma;Cancer Chemotherapy and Pharmacology;1995
4. Interleukin-5 induces tumor suppression by peritoneal exudate cells in mice;Cancer Immunology Immunotherapy;1993-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3